Jeremy VisserDec 13, 20231 minVIDEO: Abrocitinib safe and efficacious in AD patients with or without allergic comorbiditiesAbrocitinib is efficacious and well tolerated in AD patients with or without allergic comorbidities.
Jeremy VisserNov 30, 20231 minVIDEO: Pruritus, pain are main drivers of AD impact and HRQoL, according to studyPain and pruritus are the main contributors to AD burden and poor health-related QoL.
Jeremy VisserNov 22, 20231 minVIDEO: Study shows PsO patients with pruritis, sleep disturbances experience lower QoL in all domainPsoriasis patients with pruritis and related sleep distrubances showed a lower quality of life in all domains.
Jeremy VisserNov 15, 20231 minVIDEO: Researchers create new tool to predict psoriatic arthritis in psoriasis patientsResearchers developed a PRESTO tool using clinical variables to predict PsA risk in PsO patients with reasonable accuracy.